Evidence map›Paper›PMID 31219087›Full record

ArticleThe Indian journal of medical research2019

Plasmid profiles among some ESKAPE pathogens in a tertiary care centre in south India.

Naveen Kumar Devanga Ragupathi, Yamuna Devi Bakthavatchalam, Purva Mathur, Agila Kumari Pragasam, Kamini Walia, V C Ohri, Balaji Veeraraghavan

Abstract read
In one paragraph

Article in The Indian journal of medical research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Circulation of a UniqueAntibiotics (Basel, Switzerland) · 2025
    Article
  3. Article
  4. Article
  5. Hypervirulent Capsular Serotypes K1 and K2International journal of molecular sciences · 2024
    Article
  6. Antimicrobial resistance in food-associatedBioscience of microbiota, food and health · 2024
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Colistin Resistance and Molecular Characterization of the Genomes ofFrontiers in cellular and infection microbiology · 2022
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Naveen Kumar Devanga RagupathiDepartment of Clinical Microbiology, Christian Medical College, Vellore, India.
Yamuna Devi BakthavatchalamDepartment of Clinical Microbiology, Christian Medical College, Vellore, India.
Purva MathurDepartment of Clinical Microbiology, All India Institute of Medical Science, New Delhi, India.
Agila Kumari PragasamDepartment of Clinical Microbiology, Christian Medical College, Vellore, India.
Kamini WaliaDivision of Epidemiology & Communicable Diseases, Indian Council of Medical Research, New Delhi, India.
V C OhriDivision of Epidemiology & Communicable Diseases, Indian Council of Medical Research, New Delhi, India.
Balaji VeeraraghavanDepartment of Clinical Microbiology, Christian Medical College, Vellore, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background & objectives: Plasmid has led to increase in resistant bacterial pathogens through the exchange of antimicrobial resistance (AMR) genetic determinants through horizontal gene transfer. Baseline data on the occurrence of plasmids carrying AMR genes are lacking in India. This study was aimed to identify the plasmids associated with AMR genetic determinants in ESKAPE pathogens. Methods: A total of 112 ESKAPE isolates including Escherichia coli (n=37), Klebsiella pneumoniae (n=48, including 7 pan-drug susceptible isolates), Acinetobacter baumannii (n=8), Pseudomonas aeruginosa (n=1) and Staphylococcus aureus (n=18) were analyzed in the study. Isolates were screened for antimicrobial susceptibility and whole genome sequencing of isolates was performed using Ion Torrent (PGM) sequencer. Downstream data analysis was done using PATRIC, ResFinder, PlasmidFinder and MLSTFinder databases. All 88 whole genome sequences (WGS) were deposited at GenBank. Results: Most of the study isolates showed resistant phenotypes. As analyzed from WGS, the isolates included both known and unknown sequence types. The plasmid analysis revealed the presence of single or multiple plasmids in the isolates. Plasmid types such as IncHI1B(pNDM-MAR), IncFII(pRSB107), IncFIB(Mar), IncFIB(pQil), IncFIA, IncFII(K), IncR, ColKP3 and ColpVC were present in K. pneumoniae. In E. coli, IncFIA, IncFII, IncFIB, Col(BS512), IncL1, IncX3 and IncH were present along with other types. S. aureus harboured seven different plasmid groups pMW2 (rep 5), pSAS1 (rep 7), pDLK1 (rep 10), pUB110 (rep US12), Saa6159 (rep 16), pKH12 (rep 21) and pSA1308 (rep 21). The overall incidence of IncF type plasmids was 56.5 per cent followed by Col type plasmids 18.3 per cent and IncX 5.3 per cent. Other plasmid types identified were <5 per cent. Interpretation & conclusions: Results from the study may serve as a baseline data for the occurrence of AMR genes and plasmids in India. Information on the association between phenotypic and genotypic expression of AMR was deciphered from the data. Further studies on the mechanism of antibiotic resistance dissemination are essential for enhancing clinical lifetime of antibiotics.

Indexed as

Acinetobacter baumanniiAnti-Bacterial Agentsbeta-LactamasesCross InfectionDrug Resistance, Multiple, BacterialEnterobacterEnterococcus faeciumGene Transfer, HorizontalHumansIndiaKlebsiella pneumoniaePlasmidsPseudomonas aeruginosaStaphylococcus aureusAnti-Bacterial Agentsbeta-LactamasesAntimicrobial resistance - βcol-horizontal gene transferIncF - plasmidslactamase

Identifiers

PMID31219087
PMCPMC6563733

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.